论文部分内容阅读
目的:分析自体CIK细胞治疗高龄血液肿瘤患者的发热原因,探讨护理对策。方法:对38例高龄血液肿瘤患者给予自体CIK细胞治疗,分析总结CIK细胞治疗期间的发热原因及护理经验。结果:本组38例患者共输注CIK细胞382次,出现发热48例次,其中伴有乏力(58.3%)、畏寒寒战(25.0%)、胸闷憋气(16.7%)、心悸气短(6.3%)。结论:自体CIK细胞输注不良反应少,以发热最常见,对高龄血液肿瘤患者是一种安全有效的治疗方法。
OBJECTIVE: To analyze the causes of fever of CIK cells in elderly patients with hematological malignancies and to explore nursing strategies. Methods: Thirty-eight patients with advanced hematological malignancies were treated with autologous CIK cells. The causes of fever and nursing experience during CIK cell therapy were analyzed. Results: A total of 382 CIK cells were infused in 38 patients with fever (48.3%), with fatigue (58.3%), chills (25.7%), chest tightness and suffocation (16.7% ). Conclusion: Adiponectant CIK cells have less adverse reactions of infusion and the most common fever, which is a safe and effective treatment for elderly patients with hematological malignancies.